KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Tax Assets Current Taxes Dividends payables Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Merck (MRK) Liabilities from Discontinued Operations (2020)

Historic Liabilities from Discontinued Operations for Merck (MRK) over the last 2 years, with Q4 2020 value amounting to $1.1 billion.

Merck's Liabilities from Discontinued Operations changed N/A to $1.1 billion in Q4 2020 from the same period last year, while for Dec 2020 it was $1.1 billion, marking a year-over-year change of. This contributed to the annual value of $1.1 billion for FY2020, which is N/A changed from last year.
According to the latest figures from Q4 2020, Merck's Liabilities from Discontinued Operations is $1.1 billion.
In the past 5 years, Merck's Liabilities from Discontinued Operations ranged from a high of $1.1 billion in Q4 2020 and a low of $1.1 billion during Q4 2020